Medicine recalls
|
| |
| Singapore: Recall of Famodine Tablet 20mg (Famotidine) |
| |
Health Sciences Authority (HSA) announces that Duopharma (Singapore) Pte Ltd is recalling one batch of Famodine Tablet 20mg (famotidine) (batch number: 232218) to the retail level due to an out-of-specification test result for assay.
Famotidine is indicated for benign gastric and duodenal ulceration, gastro-oesophageal reflux disease, short-term symptomatic relief of heartburn or non-ulcer dyspepsia, and Zollinger-Ellison syndrome.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-famodine-tablet-20mg-(famotidine)-2
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by HSA, and was posted on the Drug Office website on 5 Apr 2025.
Ends/Thursday, Mar 26, 2026
Issued at HKT 15:30
|
| |
|
